Arterial Coronary Disease Clinical Trial
Official title:
Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
To evaluate the performance and long-term clinical outcomes of the Xience V everolimus-eluting coronary stent system (EECSS) in the treatment of minimally selective, high risk patients in the real-world clinical practice.
Prospective, multicenter, non-randomized, post-marketing web-based registry.Patients all comers assigned for percutaneous coronary intervention (PCI) who present with at least one angiographically documented coronary artery lesion suitable for percutaneous treatment with implantation of Xience V EECSS only can be included on this Registry. ;
Observational Model: Cohort, Time Perspective: Prospective